States will receive fresh federal funding to fight prescription drug abuse through electronic databases that monitor drug prescribing and dispensing activity, if Congress approves a proposed new "National All Schedules Prescription Electronic Reporting Act."
The bill, which is being proposed by a bipartisan group of lawmakers including Senators Jeff Sessions (R, Ala) and Edward Kennedy (D, Mass), aims to fight prescription drug diversion and abuse throughout the country.
The nation's "law enforcement officials want to stop the flow of prescription drugs to the streets," and a national electronic monitoring program will be a "valuable resource" to help them, Kennedy said in endorsing the bill.
Although 19 states currently operate their own electronic Rx monitoring systems, officials concede that these programs vary widely in terms of the methods used to collect and store data. States also impose inconsistent rules governing the use of prescribing and dispensing informationan issue that worries privacy advocates.
A national system funded by the federal government "must include strong safeguards for medical privacy, and must make certain that the database cannot be used to bring improper pressure on physicians to avoid prescribing essential medication for patients in need," Kennedy said.
Mr. Rankin is a freelance medical writer.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs